Clinical Trials Browser

INDUSTRY × Interventional × Moxifloxacin × Clear all

NCT05481528 2023-05-09

A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT03258515 2020-02-20

A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers

Phase 1 Completed

Long QT Syndrome

NCT00861029 2017-11-14

VEG111485: A QTc Study of Pazopanib

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasms

NCT02056392 2015-11-09

To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers

Phase 1 Completed

54 enrolled 31 charts

Other solid neoplasm

Solid Tumours

NCT01017731 2015-06-10

Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes

Phase 2 Completed

68 enrolled 13 charts

Neoplasm Metastasis, Neoplasms

NCT00708903 2012-05-14

Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)

Phase 1 Completed

Breast Neoplasms